KIMBERLY QUINN: Open Payments
NPI 1447881552 · SHENANDOAH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,141 in 46 payments from 16 companies in 2025. Trend: 2023 $1,164 · 2024 $1,680 · 2025 $1,141
Food & beverage: $1,141
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $253 |
| Actelion Pharmaceuticals US, Inc. | 5 | $149 |
| ABIOMED | 1 | $144 |
| Abbott Laboratories | 1 | $126 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $88 |
| Medtronic, Inc. | 3 | $72 |
| BridgeBio Pharma, Inc. | 2 | $71 |
| Amgen Inc. | 3 | $59 |
| Boston Scientific Corporation | 1 | $39 |
| AtriCure, Inc. | 1 | $36 |
Products named: LEQVIO, CARDIOMEMS, OPSUMIT, LifeVest, Attruby, REPATHA, PLASMABLADE(TM), WATCHMAN FLX.
Industry payments across TX — which companies pay providers there.
